CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ), the Broad Institute of Harvard and MIT, and Medicines for Malaria Ventures (MMV) today announced that its scientists presented several posters, in addition to an oral presentation, this week at the American Society of Tropical Medicine and Hygiene (ASTMH) in New Orleans, La. The research focused on progress these organizations have made through their ongoing collaboration to develop improved treatment therapies for malaria. Genzyme is conducting this research within its Humanitarian Assistance for Neglected Diseases (HAND) initiative, through which the company participates in efforts to advance treatments for neglected diseases.
